Live from ASH 2024 | First Dataset of Olverembatinib in Combination with Bcl-2 Inhibitor Lisaftoclax Demonstrates Potential Clinical Benefits as a Chemotherapy-Free Regimen for Children with R/R Ph+ ALL

ROCKVILLE, Md. and SUZHOU, China, Dec. 10, 2024 /PRNewswire/ — Ascentage Pharma…
District neighboring Hong Kong attracts global investment for commerce, trade, and cultural tourism

District neighboring Hong Kong attracts global investment for commerce, trade, and cultural tourism

SHENZHEN, China, Dec. 10, 2024 /PRNewswire/ — Luohu district of Shenzhen, an…
Noah Holdings 2024 Corporate Open Day: Driving Global Expansion and Sophisticated Solutions for Mandarin-Speaking Clients

Noah Holdings 2024 Corporate Open Day: Driving Global Expansion and Sophisticated Solutions for Mandarin-Speaking Clients

SHANGHAI, Dec. 10, 2024 /PRNewswire/ — Noah Holdings recently hosted its 2024 Corporate…
Infinix Introduces Vibrant New Colors for the HOT 50 Series: A Bold Lifestyle Statement for the New Year

Infinix Introduces Vibrant New Colors for the HOT 50 Series: A Bold Lifestyle Statement for the New Year

HONG KONG, Dec. 10, 2024 /PRNewswire/ — Infinix, a trendy tech brand crafted…
Introducing the Gianna Lullume Smart Infant Sleep Device: A Revolutionary Solution for Infant Sleep Now on Kickstarter

Introducing the Gianna Lullume Smart Infant Sleep Device: A Revolutionary Solution for Infant Sleep Now on Kickstarter

HONG KONG, Dec. 10, 2024 /PRNewswire/ — The Gianna Lullume Smart Infant Sleep…
PENTAX Medical obtained US FDA 510(k) clearance for new models of the PENTAX Medical i20c Video Endoscope Series

PENTAX Medical obtained US FDA 510(k) clearance for new models of the PENTAX Medical i20c Video Endoscope Series

MONTVALE, N.J., Dec. 10, 2024 /PRNewswire/ — PENTAX Medical, a division of…

Recurrent Energy Signs 300 MW Power Purchase Agreement with Major U.S. Tech Company in Spain

KITCHENER, ON, Dec. 10, 2024 /PRNewswire/ — Recurrent Energy, a subsidiary of Canadian…

Syntara announces positive interim data in Phase 2 study of SNT-5505 in myelofibrosis

SYDNEY, Dec. 10, 2024 /PRNewswire/ — Syntara Limited (ASX:SNT), a clinical-stage drug…